Table 1 Summary of HCMV-tetramer in HLA-A2 individual groups
Age(yr.) (n = 469) | 0–4 (n = 179) | 5–9 (n = 97) | 10–14 (n = 94) | 15–19 (n = 50) | 20–29 (n = 28) | 60–92 (n = 21) |
|---|---|---|---|---|---|---|
Number of tet(+) | 55(31%) | 43(44%) | 49(52%) | 28(46%) | 15(54%) | 12(57%) |
CD8(%) | 18.9 ± 4.7 | 21.5 ± 7.4 | 20.2 ± 6.9 | 20.3 ± 6.7 | 24.8 ± 7.1 | 23.2 ± 9.6 |
Tet(%) | 0.19 ± 0.23 | 0.18 ± 0.25 | 0.22 ± 0.31 | 0.23 ± 0.19 | 0.41 ± 0.54 | 1.49 ± 1.79 |
Tet/CD8(%) | 1.05 ± 1.30 | 0.85 ± 1.04 | 1.02 ± 1.36 | 1.14 ± 0.96 | 1.55 ± 1.71 | 5.76 ± 4.19 |